A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder
Open accessAbstract
Objective: To assess the efficacy of liraglutide 3.0 mg, a glucagon‐like peptide‐1 (GLP‐1) receptor agonist, for binge eating disorder (BED). Methods: Adults with a body mass index (BMI) ≥ 27 kg/m 2 enrolled in a pilot, 17‐week double‐blind, randomized controlled trial of liraglutide 3.0 mg/day for BED. The primary outcome was number of objective binge episodes (OBEs)/week. Binge remission, weight change, and psychosocial variables were secondary outcomes. Mixed effect models were used for continuous variables, and generalized estimating equations were used for remission rates. Results: Participants ( n = 27) were 44.2 ± 10.6 years; BMI = 37.9 ± 11.8 kg/m 2 ; 63% women; and 59% White and 41% Black. At baseline, the liraglutide group ( n = 13) reported 4.7 ± 0.7 OBEs/week, compared with 3.0 ± 0.7 OBEs/week for the placebo group, p = 0.07. At week 17, OBEs/week decreased by 4.0 ± 0.6 in liraglutide participants and by 2.5 ± 0.5 in placebo participants ( p = 0.37, mean difference = 1.2, 95% confidence interval 1.3, 2.0). BED remission rates of 44% and 36%, respectively, did not differ. Percent weight loss was significantly greater in the liraglutide versus the placebo group (5.2 ± 1.0% vs. 0.9 ± 0.7%, p = 0.005). Conclusion: Participants in both groups reported reductions in OBEs, with the liraglutide group showing clinically meaningful weight loss. A pharmacy medication dispensing error was a significant limitation of this study. Further research on liraglutide and other GLP‐1 agonists for BED is warranted.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In a 17-week pilot RCT, liraglutide 3.0 mg led to greater weight loss (-5.2% vs −0.9%, p=0.005) but no significant difference in binge remission or reduction in binge episodes compared to placebo.
“In a 17-week pilot RCT, liraglutide 3.0 mg led to greater weight loss (–5.2% vs. − 0.9%, p = 0.005) but no significant difference in binge remission or reduction in binge episodes compared to placebo.”
From Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan (2025) · cites this paper as [138]
The Results (Table 3 and “Binge-eating outcomes”) support the 17-week comparison: weight loss differed significantly (p = 0.005), while reductions in binge episodes and remission rates did not. The Results report 5.1% weight loss with liraglutide, however, rather than the claimed 5.2%; the placebo figure is 0.9%. (LLM, conf=0.88)
Experimental — accuracy not yet measuredBoth groups in that trial showed improvements in binge eating episodes.
“Both groups showed improvements in binge eating episodes, highlighting the need for further research in BED [138].”
From Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan (2025) · cites this paper as [138]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369 · see citing works
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910 · see citing works
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139 · see citing works
(1998) · PubMed · Cited by 10,216 · see citing works
(1976) · Medical Entomology and Zoology · Cited by 8,899 · see citing works
The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger
Stunkard, A. J., & Messick, S. (1985) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(85)90010-8 · Cited by 4,687 · see citing works
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371 · see citing works
How Many Imputations are Really Needed? Some Practical Clarifications of Multiple Imputation Theory
Graham, J. W., Olchowski, A. E., & Gilreath, T. D. (2007) · Prevention Science · doi:10.1007/s11121-007-0070-9 · Cited by 2,795 · see citing works
The assessment of binge eating severity among obese persons
Gormally, J., Black, S., Daston, S., & Rardin, D. (1982) · Addictive Behaviors · doi:10.1016/0306-4603(82)90024-7 · Cited by 2,129 · see citing works
(1993) · PubMed · Cited by 1,900 · see citing works
Mechanisms, Pathophysiology, and Management of Obesity
Heymsfield, S. B., & Wadden, T. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1514009 · Cited by 1,867 · see citing works
Self-citationKessler, R. C., Berglund, P. A., Chiu, W. T., Deitz, A. C., Hudson, J. I., Shahly, V., Aguilar-Gaxiola, S., Alonso, J., Angermeyer, M. C., Benjet, C., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.020 · Cited by 1,338 · see citing works
Cognitive Behavior Therapy and Eating Disorders
Mitchell, J. E. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09bk05121 · Cited by 886 · see citing works
Udo, T., & Grilo, C. M. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.03.014 · Cited by 799 · see citing works
van Can, J., Sloth, B., Jensen, C. B., Flint, A., Blaak, E. E., & Saris, W. H. M. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.162 · Cited by 537 · see citing works
A Two-Year Randomized Trial of Obesity Treatment in Primary Care Practice
Wadden, T. A., Volger, S., Sarwer, D. B., Vetter, M. L., Tsai, A. G., Berkowitz, R. I., Kumanyika, S., Schmitz, K. H., Diewald, L. K., Barg, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109220 · Cited by 487 · see citing works
Self-citationColumbia-Suicide Severity Rating Scale (C-SSRS)
Shahid, A., Wilkinson, K., Marcu, S., & Shapiro, C. M. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9893-4_24 · Cited by 384 · see citing works
McElroy, S. L., Hudson, J. I., Mitchell, J. E., Wilfley, D., Ferreira-Cornwell, M. C., Gao, J., Wang, J., Whitaker, T., Jonas, J., & Gasior, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2162 · Cited by 322 · see citing works
DSM‐IV psychiatric disorder comorbidity and its correlates in binge eating disorder
Grilo, C. M., White, M. A., & Masheb, R. M. (2008) · International Journal of Eating Disorders · doi:10.1002/eat.20599 · Cited by 306 · see citing works
Binge-Eating Disorder in Adults
Brownley, K. A., Berkman, N. D., Peat, C. M., Lohr, K. N., Cullen, K., Bann, C., & Bulik, C. M. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2455 · Cited by 285 · see citing works
McElroy, S. L., Hudson, J. I., Capece, J. A., Beyers, K., Fisher, A. C., & Rosenthal, N. R. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.008 · Cited by 279 · see citing works
Co-Occurrence of Binge Eating Disorder With Psychiatric and Medical Disorders
Javaras, K. N., Pope, H. G., Lalonde, J. K., Roberts, J. L., Nillni, Y. I., Laird, N. M., Bulik, C. M., Crow, S. J., McElroy, S. L., & Walsh, B. T. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0213 · Cited by 241 · see citing works
Wilfley, D. E., Crow, S. J., Hudson, J. I., Mitchell, J. E., Berkowitz, R. I., Blakesley, V. A., & Walsh, B. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06121970 · Cited by 142 · see citing works
Self-citationQuality of life in eating disorders: a meta-analysis
Winkler, L. A.-D., Christiansen, E., Lichtenstein, M. B., Hansen, N. B., Bilenberg, N., & Støving, R. K. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.05.002 · Cited by 141 · see citing works
Citalopram in the Treatment of Binge-Eating Disorder
McElroy, S. L., Hudson, J. I., Malhotra, S., Welge, J. A., Nelson, E. B., & Keck, P. E. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0711 · Cited by 124 · see citing works
Multilevel modeling of longitudinal data for psychotherapy researchers: II. The complexities
Gallop, R., & Tasca, G. A. (2009) · Psychotherapy Research · doi:10.1080/10503300902849475 · Cited by 104 · see citing works
Robert, S. A., Ghani, R. A., Shah, S. A., Chinna, K., Mohamud, W. N. W., & Kamaruddin, N. A. (2015) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2015.03.005 · Cited by 104 · see citing works
Chao, A. M., Wadden, T. A., Walsh, O. A., Gruber, K. A., Alamuddin, N., Berkowitz, R. I., & Tronieri, J. S. (2019) · Obesity · doi:10.1002/oby.22653 · Cited by 84 · see citing works
Self-citationGuerdjikova, A. I., McElroy, S. L., Winstanley, E. L., Nelson, E. B., Mori, N. N., McCoy, J., Keck, P. E., & Hudson, J. I. (2011) · International Journal of Eating Disorders · doi:10.1002/eat.20946 · Cited by 83 · see citing works
Blaine, B., & Rodman, J. (2007) · Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity · doi:10.1007/bf03327579 · Cited by 66 · see citing works
Placebo response in binge eating disorder
Jacobs-Pilipski, M. J., Wilfley, D. E., Crow, S. J., Walsh, B. T., Lilenfeld, L., West, D. S., Berkowitz, R. I., Hudson, J. I., & Fairburn, C. G. (2006) · International Journal of Eating Disorders · doi:10.1002/eat.20287 · Cited by 44 · see citing works
Self-citationIvezaj, V., Kalebjian, R., Grilo, C. M., & Barnes, R. D. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.05.006 · Cited by 39 · see citing works
Treatment of obese patients with binge eating disorder using topiramate: a review
Leombruni, P. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3420 · Cited by 38 · see citing works
Validation of the yale‐brown obsessive compulsive scale modified for binge eating
Deal, L. S., Wirth, R. J., Gasior, M., Herman, B. K., & McElroy, S. L. (2015) · International Journal of Eating Disorders · doi:10.1002/eat.22407 · Cited by 36 · see citing works
An open-label efficacy trial of escitalopram for night eating syndrome
Allison, K. C., Studt, S. K., Berkowitz, R. I., Hesson, L. A., Moore, R. H., Dubroff, J. G., Newberg, A. B., & Stunkard, A. J. (2013) · Eating Behaviors · doi:10.1016/j.eatbeh.2013.02.001 · Cited by 32 · see citing works
Self-citationMasheb, R. M., White, M. A., & Grilo, C. M. (2013) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2013.03.017 · Cited by 23 · see citing works
Flagged first, then by citations
2 of the 38 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
GLP-1 and Its Analogs: Does Sex Matter?
Börchers, S., & Skibicka, K. P. (2024) · Endocrinology · doi:10.1210/endocr/bqae165 · Cited by 91 · see citing works
Use of glucagon‐like peptide‐1 receptor agonists in eating disorder populations
Bartel, S., McElroy, S. L., Levangie, D., & Keshen, A. (2024) · International Journal of Eating Disorders · doi:10.1002/eat.24109 · Cited by 81 · see citing works
Giorgi, R. D., Ghenciulescu, A., Dziwisz, O., Taquet, M., Adler, A., Koychev, I. G., Upthegrove, R., Solmi, M., McCutcheon, R. A., Pillinger, T., et al. (2025) · Nature Mental Health · doi:10.1038/s44220-025-00390-x · Cited by 90 · see citing works
The Impact of GLP-1 Receptor Agonists (GLP-1 RAs) on Mental Health: A Systematic Review
Valenta, S. T., Nicastri, A., Perazza, F., Marcolini, F., Beghelli, V., Atti, A. R., & Petroni, M. L. (2024) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-024-00331-y · Cited by 47 · see citing works
Alur-Gupta, S., Dokras, A., & Cooney, L. G. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.01.018 · Cited by 53 · see citing works
Subhani, M., Dhanda, A., King, J. A., Warren, F. C., Creanor, S., Davies, M. J., Eldeghaidy, S., Bawden, S., Gowland, P. A., Bataller, R. A., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102920 · Cited by 43 · see citing works
Radkhah, H., Anaraki, S. R., Roudsari, P. P., Bahri, R. A., Zooravar, D., Asgarian, S., Dolama, R. H., Alirezaei, A., & Khalooeifard, R. (2025) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-025-01720-9 · Cited by 44 · see citing works
The emerging role of glucagon-like peptide 1 in binge eating
Balantekin, K. N., Kretz, M. J., & Mietlicki-Baase, E. G. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0405 · Cited by 38 · see citing works
Cooney, L. G., Gyorfi, K. M., Sanneh, A., Bui, L. M., Mousa, A., Tay, C. T., Teede, H. J., Stener‐Victorin, E., & Brennan, L. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae462 · Cited by 35 · see citing works
GLP-1 Receptor Agonists in Pediatric and Adolescent Obesity
Stefater‐Richards, M. A., Jhe, G., & Zhang, Y. J. (2025) · PEDIATRICS · doi:10.1542/peds.2024-068119 · Cited by 33 · see citing works
Tuccinardi, D., Masi, D., Watanabe, M., Zanghi Buffi, V., De Domenico, F., Berti, S., Cipriani, V., Manco, M., Manfrini, S., & Pagotto, U. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02700-7 · Cited by 29 · see citing works
The evolving profile of eating disorders and their treatment in a changing and globalised world
Himmerich, H., Keeler, J. L., Davies, H. L., Tessema, S. A., & Treasure, J. L. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00874-2 · Cited by 26 · see citing works
Reward and Inhibitory Control as Mechanisms and Treatment Targets for Binge Eating Disorder
Pasquale, E. K., Boyar, A., & Boutelle, K. N. (2024) · Current Psychiatry Reports · doi:10.1007/s11920-024-01534-z · Cited by 22 · see citing works
Tsompanaki, E., Koutoukidis, D. A., Wren, G., Tong, H., Theodoulou, A., Wang, D., Park, R. J., Jebb, S. A., & Aveyard, P. N. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.103049 · Cited by 20 · see citing works
Kałas, M., Stępniewska, E., Gniedziejko, M., Leszczyński-Czeczatka, J., & Siemiński, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14093122 · Cited by 19 · see citing works
Tongta, S., Sungkaworn, T., & Pathomthongtaweechai, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210974 · Cited by 18 · see citing works
Meshkat, S., Luciano, C. D., Swiderski, A., Li, G., Aguilar, R. J., Dunkley, B. T., Reichelt, A. C., Zhang, Y., Greenshaw, A. J., Vermetten, E. H. G. J. M., et al. (2025) · Brain and Behavior · doi:10.1002/brb3.70661 · Cited by 13 · see citing works
Psychotropic effects of GLP-1R agonists
Bucciarelli, L. G., Cimino, V., Dell’Osso, B. M., & Fiorina, P. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108036 · Cited by 13 · see citing works
Knowles, L. G., Armanious, A. J., Peng, Y., Welsh, W. J., & James, M. H. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100126 · Cited by 10 · see citing works
Anti-obesity Drugs for the Treatment of Binge Eating Disorder: Opportunities and Challenges
Riboldi, I., & Carrà, G. (2024) · ALPHA PSYCHIATRY · doi:10.5152/alphapsychiatry.2024.241464 · Cited by 10 · see citing works
Glucagon-Like Peptide 1 Receptor Agonists in Psychiatry
Himmerich, H., & McElroy, S. L. (2024) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001869 · Cited by 10 · see citing works
Brain Activity Associated with Breakthrough Food Preoccupation in an Individual on Tirzepatide
Choi, W., Nho, Y.-H., Qiu, L., Chang, A., Campos, G., Seilheimer, R. L., Wilent, W. B., Bakalov, D., Firdous, N., Kerr, M., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-04035-5 · Cited by 10 · see citing works
Self-citationGLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders
Guo, J. S., Hayes, M. R., Leggio, L., Oru, E., & Rinaman, L. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1375-25.2025 · Cited by 9 · see citing works
Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin
Steward, T. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.12.001 · Cited by 8 · see citing works
Can we effectively manage binge eating disorder with pharmacotherapy?
Hay, P., de Moraes, C. E. F., & Appolinário, J. C. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2428371 · Cited by 8 · see citing works
Nunns, M., Febrey, S., Buckland, J., Abbott, R. A., Whear, R., Bethel, A. C., Boddy, K., Shaw, L., Coon, J. T., & Meléndez‐Torres, G. J. (2024) · Health Technology Assessment · doi:10.3310/skht8119 · Cited by 9 · see citing works
Schaefer, L. M., Williams‐Kerver, G. A., Allison, K. C., Kohoutek, B., & Steffen, K. J. (2025) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2025.08.013 · Cited by 8 · see citing works
Self-citationJoy, B., Ramsamooj, A., Ibrahim, S., Wen, J., Hsu, N., & Frezza, E. (2026) · Endocrine · doi:10.1007/s12020-025-04494-3 · Cited by 10 · see citing works
Himmerich, H. (2025) · Der Nervenarzt · doi:10.1007/s00115-025-01813-x · Cited by 6 · see citing works
GLP-1R Agonists for Weight Loss in Psychiatric Disorders: A Systematic Review and Meta-analysis
Alves, K. M., da Silva, M. T., Kramer, C. K., & Viana, L. V. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf150 · Cited by 9 · see citing works
Pharmacotherapies for Binge Eating Disorder: Systematic Review and Network Meta‐Analysis
Costa, G. P. A., de Assunção, B. R., Belfort‐DeAguiar, R., & Nunes, J. C. (2025) · Obesity Reviews · doi:10.1111/obr.13936 · Cited by 6 · see citing works
Update on eating disorders and disordered eating behaviors in metabolic bariatric surgery patients
Conceição, E., Mitchell, J. E., & Sarwer, D. B. (2024) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000962 · Cited by 5 · see citing works
Castro, N. I. Q., Almeida, M., Orbea, A. F., Andrade, D. N., Carrera, J. F., Vargas, F. Y., & Carrasco, M. L. (2025) · Cureus · doi:10.7759/cureus.82479 · Cited by 5 · see citing works
Obesity and eating disorders: an interactive and complex coexistence
Grave, R. D. (2023) · IJEDO · doi:10.32044/ijedo.2023.04 · Cited by 5 · see citing works
Reilly-Harrington, N. A., Himes, S. M., Lauretti, J. M., & Sogg, S. (2025) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2025.02.004 · Cited by 4 · see citing works
Leziak, A., Kochman, K., & Kocełak, P. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.03.008 · Cited by 4 · see citing works
Choudhury, I., Ward, J. H., Mahesh, S., Alam, U., Azmi, S., & Anson, M. (2026) · Clinical Therapeutics · doi:10.1016/j.clinthera.2026.02.010 · Cited by 4 · see citing works
Keel, P. K., Bodell, L. P., Ali, S. I., Starkey, A. G., Trotta, J., Luxama, J. W., Halfhide, C., Hill, N. G., Appelbaum, J., & Williams, D. L. (2025) · JMIR Research Protocols · doi:10.2196/66554 · Cited by 5 · see citing works
Nutrition and Eating Disorders
Bruzas, M. B., & Allison, K. C. (2023) · Nutrition and health · doi:10.1007/978-3-031-24663-0_11 · Cited by 4 · see citing works
Self-citationKeel, P. K., Bodell, L. P., Appelbaum, J., & Williams, D. L. (2025) · Psychological Medicine · doi:10.1017/s0033291725100871 · Cited by 3 · see citing works
Maynard, S., Hay, P., Chimoriya, R., Reyes, P. A., Grudzinskas, K., Kormas, N., & Piya, M. K. (2025) · International Journal of Eating Disorders · doi:10.1002/eat.24575 · Cited by 3 · see citing works
Patient experiences with liraglutide for obesity and binge eating disorder–A qualitative study
Følling, I. S., Reigstad, S. L., Hyldmo, Å. A., & Helvik, A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0335806 · Cited by 4 · see citing works
de Moraes, C. E. F., Donnelly, B., Appolinário, J. C., & Hay, P. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2273392 · Cited by 3 · see citing works
Jing, E., Gregertsen, E. C., Chen, L., & Russell, J. D. (2024) · Australasian Psychiatry · doi:10.1177/10398562241249906 · Cited by 3 · see citing works
Dulaglutide use to improve binge eating behaviors in a person with type 2 diabetes and obesity
Innocent, B., Elmaoued, A. A., Cowart, K., & White, R. T. (2025) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaf088 · Cited by 3 · see citing works
Interventions for Weight Management in Binge-Eating Disorder: Current Findings and Issues
Grilo, C. M. (2025) · Current Psychiatry Reports · doi:10.1007/s11920-025-01630-8 · Cited by 2 · see citing works
Hirsch, D., Reed, J., Naqvi, A., Ngor, A., Dugan, L., Costa, K., Ganasi, R. S., Truman, K. A., Danovitch, I., IsHak, W. W., et al. (2025) · CNS Drugs · doi:10.1007/s40263-025-01248-7 · Cited by 2 · see citing works
Starostina, E. G., & Ананян, М. В. (2026) · Diabetes Mellitus · doi:10.14341/dm13410 · Cited by 2 · see citing works
Incretin‐Based Therapies for the Treatment of Binge Eating—A Systematic Review
White, R. T., Henriquez, P., Innocent, B., Bullers, K., & Elmaoued, A. A. (2026) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.70135 · Cited by 2 · see citing works
Škudar, S. (2026) · International Journal of Eating Disorders · doi:10.1002/eat.70145 · Cited by 2 · see citing works
Emptage, I., Kozmér, S., Cobham-Wilson, A., Sousa, B., Sugden, K., Wheeler, L., Llewellyn, C. H., Makaronidis, J., Bulik, C. M., Solmi, F., et al. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.104007 · Cited by 2 · see citing works
Hay, P., Appolinário, J. C., Giel, K. E., Keshen, A. R., Mitchison, D., Schmidt, U., Steward, T., & Stice, E. M. (2026) · Nature Reviews Disease Primers · doi:10.1038/s41572-026-00726-6 · Cited by 2 · see citing works
Grayson, K., Russell, M., Scott, R., & Rodriguez, A. J. (2026) · Sleep Epidemiology · doi:10.1016/j.sleepe.2026.100128 · Cited by 1 · see citing works
Resistant and Refractory Obesity: The Complexity of Anti-Obesity Therapy Failure
Nicze, M., Borówka, M., Dec, A., Bułdak, Ł., Bołdys, A., & Okopień, B. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062539 · Cited by 1 · see citing works
Efficacy and safety of semaglutide for obesity and hyperphagia in adults with Prader-Willi syndrome
Shahd, A., Bridges, N., & Goldstone, A. P. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1881392 · Cited by 1 · see citing works
Second Generation Anti-Obesity Medications
Chimatapu, S. N., Mittelman, S. D., & Singhal, V. (2024) · Current Pediatrics Reports · doi:10.1007/s40124-024-00326-6 · Cited by 1 · see citing works
Glucagon-like Peptide 1 Receptor Agonists and Obesity Associated with Eating Disorders
Grave, R. D. (2024) · IJEDO · doi:10.32044/ijedo.2024.02 · Cited by 1 · see citing works
Hornack, S. E., Vaidya, S. S., Chevinsky, J. D., O’Connor, R. J., & Latif, F. (2025) · Psychiatric Annals · doi:10.3928/00485713-20250915-02 · Cited by 1 · see citing works
Standard Binge Eating Treatments Are Not Effective for My Patient
McElroy, S. L. (2023) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001789
Binge-Eating Disorder: General Information
Grave, R. D., Sartirana, M., & Calugi, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-71456-6_1
Grave, R. D., Sartirana, M., & Calugi, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-71456-6_12
Neuroendocrine Function and the Gut–Brain Axis in Eating Disorders
Williams, D. L., & Keel, P. K. (2025) · doi:10.1093/9780197675212.003.0004
Guerdjikova, A. I., Blom, T. J., Mori, N. N., Romo‐Nava, F., & McElroy, S. L. (2025) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2025.2549307
Innovative Pharmacological Approaches to Eating Disorder Treatment
Keshen, A. R., Touyz, S. W., Lacroix, E., Hay, P., & McElroy, S. L. (2025) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2025.08.014
Blažytė, J., & Strumila, R. (2024) · Neurologijos seminarai · doi:10.15388/ns.2024.28.102.1
Violante-Cumpa, J. R., Rios-Ortega, A. G., Sánchez‐García, A., Treviño‐Alvarez, A. M., Gonzalez‐Cruz, D., Manzanares-Gallegos, D. M., Gutiérrez-Dávila, L. F., Moreno-Alvarado, M., Montelongo-Cepeda, J. E., Fuentes-Cepeda, A. D. L., et al. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2025.11.002
Hung, T.-H., Chen, C.-R., Hsu, C., Carvalho, A. F., Stubbs, B., Tseng, P., Wang, L., & Lin, P. (2026) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.70041
Barrett, P., Brooks, C. P., McCluskey, S., & Brown, A. (2026) · Journal of Eating Disorders · doi:10.1186/s40337-026-01634-6
Mazurkiewicz, W., Borecka, Z., Sobczak, A. M., Szymczak, A., Jaworowicz, A., Piasecka, J., Gołembiewski, B., Mulski, G., Manicka, M., & Baranowicz, M. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5166
Du, J., Yang, Z., & Chen, Y. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1870484 · Cited by 1 · see citing works
Sosnowska, M., & Czupryniak, L. (2026) · Endocrines · doi:10.3390/endocrines7030048
Klusek, K., Batory, M., Jakubowski, J., Kraska, K., Krasucka, N., Zynkowska, A., Skrzyniarz, A. M., Kiełbus, M., Oziębło, J., & Kijowska, M. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6114
Treatment of hyperphagia and obesity in Prader–Willi syndrome
Höybye, C., Forster, J. L., Goldstone, A. H., Gourash, L. M., Miller, J., & Tauber, M. (2026) · Journal of Internal Medicine · doi:10.1111/joim.70173
Fagiolini, A. M., & Cuomo, A. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.10.039
- Authors
- Allison, K. C., Chao, A. M., Bruzas, M. B., McCuen‐Wurst, C., Jones, E., McAllister, C., Gruber, K., Berkowitz, R. I., Wadden, T. A., & Tronieri, J. S.
- Affiliations
- University of Pennsylvania (US)
- Children's Hospital of Philadelphia (US)
- Corresponding author
- Allison, Kelly C.
- Venue
- Obesity Science & Practice
- Publisher
- Wiley
- Published
- 2022-07-26
- Volume
- 9
- Issue
- 2
- Pages
- 127-136
- ISSN
- 2055-2238 (ISSN-L)
- PMC
- PMC10073825
- OpenAlex
- W4282044710
- Cited by
- 75
- References
- 38
- Citations by year
- 2026: 20 · 2025: 28 · 2024: 19 · 2023: 7 · 2022: 1
- FWCI
- 12.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Obesity Science & Practice (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Novo Nordisk (Investigator Initiated Study)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
- Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- liraglutide, binge eating disorder, GLP-1 receptor agonists, weight loss, obesity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
